BASKING RIDGE, N.J., Jan. 29, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively ...

Use of a novel inflatable sheath that eases transfemoral access appears feasible and safe, making the approach available to many patients with PAD, reports a small study published online January 30, ...

Specific lots of three coronary catheters have been recalled by Abbott Vascular due to potential difficulty in removing the protective balloon sheath, an issue that has resulted in at least one ...

patients in the study received aspirin and clopidogrel as background therapy. The primary endpoint of the study was major bleeding within 48 hours. Important secondary endpoints were a composite of ...

Morrisville, NC - The first major study to use a new monitor, which measures the extent of anticoagulation provided by enoxaparin, should encourage more cardiologists to use this low-molecular-weight ...

Complications may arise at any stage of the procedure, and while they commonly relate to vascular access, can also result from trauma during device tracking, positioning or deployment. Furthermore, ...